These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3578145)

  • 21. No progress in ABO titer measurement: time to aim for a reference?
    Bentall A; Regan F; White J; Milkins C; Rowley M; Ball S; Briggs D
    Transplantation; 2014 Feb; 97(3):e19-21. PubMed ID: 24492427
    [No Abstract]   [Full Text] [Related]  

  • 22. The 1987 Comprehensive Blood Bank Survey of the College of American Pathologists.
    Cooper ES; Ryden SE; Hill JR; Harrison CR
    Arch Pathol Lab Med; 1989 Sep; 113(9):969-74. PubMed ID: 2505734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of three low-ionic-strength solutions for routine pretransfusion testing: antibody screening/identification, cross-matching, immune anti-ABO detection, and direct antiglobulin tests.
    Kaspi E; Mallié F; Gouvitsos J; Dettori I; Chiaroni J; Ferrera V
    Transfusion; 2009 Dec; 49(12):2772-3. PubMed ID: 20163691
    [No Abstract]   [Full Text] [Related]  

  • 24. Pathology consultation on electronic crossmatch.
    Mazepa MA; Raval JS; Park YA;
    Am J Clin Pathol; 2014 May; 141(5):618-24. PubMed ID: 24713731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is it time to give up the crossmatch?
    Wallis JP
    J Clin Pathol; 2000 Sep; 53(9):673-5. PubMed ID: 11041056
    [No Abstract]   [Full Text] [Related]  

  • 26. [Test for blood group incompatibility in pregnancy].
    Okubo M; Tate A; Maeda H; Suzuki M
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():803-6. PubMed ID: 20942195
    [No Abstract]   [Full Text] [Related]  

  • 27. The computer crossmatch: a safe alternative to the serological crossmatch.
    Chapman JF; Milkins C; Voak D
    Transfus Med; 2000 Dec; 10(4):251-6. PubMed ID: 11123808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new paradigm for pretransfusion testing with the same perennial limitations.
    Westhoff CM; Anstee DJ
    Transfusion; 2010 Mar; 50(3):520-1. PubMed ID: 20609198
    [No Abstract]   [Full Text] [Related]  

  • 29. Hemolysis from ABO Incompatibility.
    Simmons DP; Savage WJ
    Hematol Oncol Clin North Am; 2015 Jun; 29(3):429-43. PubMed ID: 26043383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Change in blood group phenotype.
    Balachandran V; Nair PM; Prasad K
    J Indian Med Assoc; 1996 Apr; 94(4):151, 153. PubMed ID: 8854634
    [No Abstract]   [Full Text] [Related]  

  • 31. Failure of DiaMed-ID system to detect ABO compatibility.
    Boulton FE; Nightingale M
    Lancet; 1994 Aug; 344(8920):471. PubMed ID: 7914576
    [No Abstract]   [Full Text] [Related]  

  • 32. DiaMed-ID microtyping system for detection of major ABO incompatibility.
    Knox-Macaulay H; McDonald R
    Lancet; 1994 Oct; 344(8929):1089. PubMed ID: 7934469
    [No Abstract]   [Full Text] [Related]  

  • 33. Incompatible crossmatch following nonreactive antibody detection test. Frequency and cause.
    Mintz PD; Haines AL; Sullivan MF
    Transfusion; 1982; 22(2):107-10. PubMed ID: 7071913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Can thrombocyte crossmatching improve the efficiency of platelet transfusion?].
    Weisbach V; Zeiler T; Zingsem J; Musch R; Heuft HG; Eckstein R
    Beitr Infusionsther; 1990; 26():160-2. PubMed ID: 1703820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The risk of an overt hemolytic transfusion reaction following the use of an immediate spin crossmatch.
    Shulman IA
    Arch Pathol Lab Med; 1990 Apr; 114(4):412-4. PubMed ID: 2322101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Standards for cross-matching of blood.
    ALLEN FH
    Conn Med; 1962 Oct; 26():585-8. PubMed ID: 14040755
    [No Abstract]   [Full Text] [Related]  

  • 37. Do you think that the cross match with donor red cells can be omitted when the serum of a patient has been tested for the presence of red cell alloantibodies with a cell panel?
    Vox Sang; 1982; 43(3):151-68. PubMed ID: 6815895
    [No Abstract]   [Full Text] [Related]  

  • 38. [Final bedside verification: results of a national survey of reagents and devices used in France].
    Noizat-Pirenne F; Le Pennec PY; Lascaux JM; Fraval D; Zaoui F; Rouger P
    Transfus Clin Biol; 1998 Dec; 5(6):392-6. PubMed ID: 9894330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [ABO blood group and subtypes].
    Okubo M; Anan M; Noro M
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():734-7. PubMed ID: 20942176
    [No Abstract]   [Full Text] [Related]  

  • 40. Safety in transfusion practice. Is it safe to eliminate the major crossmatch for selected patients?
    Shulman IA; Kent D
    Arch Pathol Lab Med; 1989 Mar; 113(3):270-2. PubMed ID: 2919957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.